Explore more publications!

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2025

TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited interim consolidated financial results for the three and nine month periods ended September 30, 2025.

Financial Highlights

  • Total assets as of September 30, 2025 amounted to approximately €759.4 million, compared to total assets as of December 31, 2024 of approximately €677.3 million.
  • Revenues1 for the three months ended September 30, 2025 were approximately €12.7 million, compared to revenues of approximately €12.3 million for the three months ended September 30, 2024. Revenues for the nine months ended September 30, 2025 were approximately €32.9 million, compared to revenues of approximately €31.8 million for the nine months ended September 30, 2024.
  • Profit for the three months ended September 30, 2025 was approximately €10.1 million, compared to profit of approximately €6.6 million for the three months ended September 30, 2024. Profit for the nine months ended September 30, 2025 was approximately €8.5 million, compared to profit of approximately €3.3 million for the nine months ended September 30, 2024.
  • EBITDA for the three months ended September 30, 2025 was approximately €22.1 million, compared to EBITDA of approximately €11 million for the three months ended September 30, 2024. EBITDA for the nine months ended September 30, 2025 was approximately €28.2 million, compared to EBITDA of approximately €17.6 million for the nine months ended September 30, 2024. See below under “Use of Non-IFRS Financial Measures” for additional disclosure concerning EBITDA.

Financial Overview for the Nine Months Ended September 30, 2025

  • Revenues1 were approximately €32.9 million for the nine months ended September 30, 2025, compared to approximately €31.8 million for the nine months ended September 30, 2024. The increase in revenues mainly results from revenues generated from the Company’s 19.8 MW and 18.1 MW Italian solar facilities that were connected to the grid in February-May 2024 and in January 2025, respectively, and from the Company’s facilities in the USA that were connected to the grid during the second quarter of 2025. Such increase was partly offset by lower revenues from the Company’s Dutch biogas plants, one of which experienced a production issue related to the bacteria used by the plant that affected output in January and April 2025 and another facility whose output was adversely affected during the summer months due to high temperatures. In addition, revenues from the Talasol facility were slightly lower in the nine months ended September 30, 2025, due to damage caused by a fire event that occurred in July 2024, that has since been repaired and restored to nearly 97% output, though not yet fully recovered.
  • Operating expenses were approximately €14.4 million for the nine months ended September 30, 2025, compared to approximately €14.5 million for the nine months ended September 30, 2024. The decrease in operating expenses mainly results from lower costs in connection with the acquisition of feedstock by the Company’s Dutch biogas plants, partially offset by the achievement of preliminary acceptance certificate (PAC) of the Company’s 19.8 MW Italian solar facilities subsequent to September 30, 2024, upon which the Company commenced recording operating expenses of the solar facilities. Depreciation and amortization expenses were approximately €12.9 million for the nine months ended September 30, 2025, compared to approximately €12.3 million for the nine months ended September 30, 2024.
  • Project development costs were approximately €3.4 million for the nine months ended September 30, 2025, compared to approximately €3.3 million for the nine months ended September 30, 2024.
  • General and administrative expenses were approximately €5.2 million for the nine months ended September 30, 2025, compared to approximately €4.7 million for the nine months ended September 30, 2024. The increase in general and administrative expenses is mostly due to higher consultancy expenses.
  • Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €17 million for the nine months ended September 30, 2025, compared to approximately €5.3 million for the nine months ended September 30, 2024. The increase in share of profits of equity accounted investee was mainly due to the recording of a gain on bargain purchase by Ellomay Luzon Energy Infrastructures Ltd. (“Ellomay Luzon Energy”), an equity accounted investee of the Company, in the amount of NIS 112.8 million (approximately €28.7 million based on the average EUR/USD exchange rate for the year 2025) in connection with the acquisition on July 22, 2025 of 15% of the outstanding share capital of Dorad Energy Ltd. (“Dorad”) by Ellomay Luzon Energy reflecting the excess of the net amount recognized at the acquisition date for the identifiable assets over the cost of the acquired Dorad shares.
  • Other income, net was approximately €1.3 million for the nine months ended September 30, 2025, compared to €2.9 for the nine months ended September 30, 2024. The other income recognized for the nine months ended September 30, 2025 is based on agreed compensation expected to be received from the EPC contractor of two of the Company’s USA solar facilities for loss of income due to delays in construction and the other income recognized for the nine months ended September 30, 2024 is based on compensation received from insurance in connection with the fire near the Talasol and Ellomay Solar facilities in Spain in July 2024, net of impairment expenses related to the damaged fixed assets.
  • Financing expense, net was approximately €8.7 million for the nine months ended September 30, 2025, compared to financing expense, net of approximately €2 million for the nine months ended September 30, 2024. The change in financing expenses, net, was mainly attributable to lower income resulting from exchange rate differences that amounted to approximately €1.6 million for the nine months ended September 30, 2025, compared to approximately €5.2 million for the nine months ended September 30, 2024, an aggregate change of approximately €3.5 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures and were caused by the 2.2% devaluation of the NIS against the euro during the nine months ended September 30, 2025, compared to 3.5% devaluation of the NIS against the euro during the nine months ended September 30, 2024. The increase in financing expense for the nine months ended September 30, 2025 was also attributable to an increase in financing expense of approximately €3.4 million in connection with derivatives and warrants for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase was partially offset by increased interest income on balances mainly deposited by the Company for short-term periods.
  • Tax benefit was approximately €1.8 million for the nine months ended September 30, 2025, compared to a tax benefit of approximately €0.1 million for the nine months ended September 30, 2024. The change is primarily attributable to the tax impact of the investment transaction with Clal Insurance Company Ltd. (“Clal”) in the Company’s 198 MW solar portfolio, which is expected to be fully offset through the utilization of current losses.
  • Profit for the nine months ended September 30, 2025 was approximately €8.5 million, compared to a profit of approximately €3.3 million for the nine months ended September 30, 2024.
  • Total other comprehensive loss was approximately €8.6 million for the nine months ended September 30, 2025, compared to total other comprehensive income of approximately €2.6 million for the nine months ended September 30, 2024. The change in total other comprehensive income (loss) is primarily as the result of foreign currency translation adjustments due to the change in the NIS/euro exchange rate and by changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the “Talasol PPA”). The Talasol PPA experienced high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows.
  • Total comprehensive loss was approximately €0.1 million for the nine months ended September 30, 2025, compared to total comprehensive income of approximately €5.9 million for the nine months ended September 30, 2024.
  • Net cash provided by operating activities was approximately €8.5 million for the nine months ended September 30, 2025, compared to approximately €5.5 million for the nine months ended September 30, 2024. The increase in net cash provided by operating activities for the nine months ended September 30, 2025, is mainly due to income produced by the Company’s Italian solar facilities that were connected to the grid in February-May 2024 and in January 2025, three of the Company’s facilities in Texas USA that were connected to the grid and commenced commissioning tests in April 2024, and 2024 related subsidies that were paid to the Company’s Dutch biogas plants in 2025.
  • In September 2025, the Company received tax credits in respect of two facilities in the USA in an aggregate amount of approximately €10 million, which were presented as cash flows provided by financing activities.

1 The revenues presented in the Company’s financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company’s investor presentation.


CEO Review for the First Nine Months of 2025

In the first nine months, the Company’s revenues amounted to approximately €32.9 million, an increase of approximately 3% in revenues compared to the corresponding period last year. Cash provided by operating activities was approximately €8.5 million in the first nine months compared to approximately €5.5 million in the corresponding period last year. The EBITDA for the first nine months of 2025 was approximately €28.2 million, compared to approximately €17.6 million in the corresponding period last year.

In the first nine months of 2025, there was a significant advancement in the construction and connection to the grid of new projects, which are expected to contribute to a significant increase in the Company’s revenues during 2026.

In Italy – 38 MW solar (51% owned in partnership with Clal) are fully operating. The construction work on additional 160 MW solar (51% owned in partnership with Clal) has begun and construction is progressing as planned and is expected to finish by the end of 2026. The remainder of the portfolio developed by the Company (100% owned) is approximately 264 MW solar, of which 210 MW have reached Ready to Build status as of the date hereof and the rest are expected to receive permits in the near future. These 264 MW are scheduled to begin construction in the last quarter of 2026. The Company signed a power purchase agreement (PPA) with a leading European entity for the operating projects with an aggregate capacity of 38 MW and the Company intends to continue to execute PPAs for the remainder of the portfolio.

In the USA – The construction of the first 4 projects (49 MW) has been completed, three of them were connected to the grid at the end of the first half of 2025 and the fourth project will be connected in the near future. The Company has begun construction of the Hillsboro project (14 MW solar + two hours of battery storage). The Company is examining the possibility of entering into the construction of two additional projects that will fall within the current tax benefit framework. The regulatory changes and the uncertainty regarding tariff rates do not allow the Company to provide a forecast beyond what has been said, but the assumption is that the Company will find a way to continue developing and increasing the portfolio in the near future.

In the Netherlands – the license to increase production at the GGOT facility was received. Licenses to increase production at the two additional facilities are in advanced stages. The new regulation for the obligation to blend green gas with fossil gas will commence according to the law in January 2027 (a delay of one year), but the targets for the first year have increased. Agreements have been signed for the sale of green certificates issued under the new regulation at a price of approximately €1 per certificate. The blending obligation is expected to significantly increase the profitability of operations in the Netherlands at current production capacity. The expected increase in production capacity from 16 million cubic meters of gas per year to around 24 million cubic meters of gas per year is expected to add significantly beyond that.

In Israel – the Company is in negotiations with the Israeli Electricity Authority for compensation for delays and war damage to the Manara project. Ellomay Luzon (50% owned) exercised its right of refusal in connection with the Zorlu-Phoenix transaction for the sale of Dorad’s shares and acquired an additional 15% of Dorad’s shares so that its holdings in Dorad are currently 33.75%. Dorad notified of the approval of its board of directors to advance to financial closing of Dorad 2 and the intention is to try to reach financial closing by June 30, 2026.

Dorad finished the third quarter with a profit of approximately NIS 118.4 million, despite a decline of approximately 10% in the USD exchange rate, which caused an accounting expense during the period of approximately NIS 69 million on Dorad’s USD deposits. Dorad has future expenses in USD (gas purchases, operation and maintenance payments, construction of Dorad 2) that constitute a natural hedge for the USD deposits. Dorad is actively advancing the establishment of the Dorad 2 project (an expansion of the existing power station using an H-type turbine with a generation capacity of approximately 700 MWh).

In Spain – The Company’s development activity in Spain focuses on energy storage in batteries, whereby the process for obtaining license for Ellomay Solar (28 MWp for two hours of battery storage) is in advanced stages and is expected to be received in the coming months. In addition, the Company is advancing a battery storage project for Talasol (120 MWp). The high volatility in electricity prices in Spain stems from an excess of renewable energy during the transition seasons and causes damage to the stability of the grid. In the Company’s assessment, the solution is a significant increase in storage capacity, which is currently at very low levels in Spain.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 14 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

  • Approximately 335.9 MW of operating solar power plants in Spain (including a 300 MW solar plant in owned by Talasol, which is 51% owned by the Company) and 51% of approximately 38 MW of operating solar power plants in Italy;
  • 16.875% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 850 MW;
  • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;
  • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
  • 51% of solar projects in Italy with an aggregate capacity of 160 MW that are under construction;
  • Solar projects in Italy with an aggregate capacity of 210 MW that have reached “ready to build” status; and
  • Solar projects in the Dallas Metropolitan area, Texas, USA with an aggregate capacity of approximately 38 MW that are connected to the grid and additional 11 MW that are awaiting connection to the grid.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza and between Israel and Iran, the outcome of legal proceedings in connection with Dorad Energy Ltd., technical and other disruptions in the operations or construction of the power plants owned by the Company, inability to obtain the financing required for the development and construction of projects, inability to advance the expansion of Dorad, increases in interest rates and inflation, changes in exchange rates, delays in development, construction, or commencement of operation of the projects under development, failure to obtain permits - whether within the set time frame or at all, climate change, the impact of the continued military conflict between Russia and Ukraine, and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: hilai@ellomay.com


Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Financial Position  
   
    September 30,     December 31,     September 30,  
    2025     2024     2025  
    € in thousands     Convenience Translation into US$ in thousands*  
Assets                  
Current assets:                  
Cash and cash equivalents     49,288       41,134       57,856  
Restricted cash     656       656       770  
Intangible asset from green certificates     419       178       492  
Trade and revenue receivables     5,461       5,393       6,410  
Other receivables     15,212       15,341       17,856  
Derivatives asset short-term     250       146       293  
Other receivables - investment transaction     4,221       -       4,955  
      75,507       62,848       88,632  
Non-current assets                        
Investment in equity accounted investee     57,545       41,324       67,548  
Advances on account of investments     -       547       -  
Fixed assets     528,851       482,747       620,784  
Right-of-use asset     41,579       34,315       48,807  
Restricted cash and deposits     15,940       17,052       18,711  
Deferred tax     11,276       9,039       13,236  
Long-term receivables     16,212       13,411       19,030  
Derivatives     12,534       15,974       14,713  
      683,937       614,409       802,829  
Total assets     759,444       677,257       891,461  
                         
Liabilities and Equity                        
Current liabilities                        
Short-term bank loans and current maturities of long-term bank loans     16,133       21,316       18,937  
Current maturities of other long-term loans     3,666       5,866       4,303  
Current maturities of debentures     12,013       35,706       14,101  
Trade payables     11,995       8,856       14,080  
Other payables     16,533       10,896       19,407  
Current maturities of derivatives     237       1,875       278  
Current maturities of lease liabilities     814       714       956  
Warrants     2,507       1,446       2,943  
      63,898       86,675       75,005  
Non-current liabilities                        
Long-term lease liabilities     33,304       25,324       39,093  
Long-term bank loans     243,627       245,866       285,978  
Other long-term loans     42,788       30,448       50,226  
Debentures     194,575       155,823       228,399  
Deferred tax     2,621       2,609       3,077  
Other long-term liabilities     8,186       939       9,609  
Derivatives     1,353       288       1,588  
      526,454       461,297       617,970  
Total liabilities     590,352       547,972       692,975  
                         
Equity                        
Share capital     27,998       25,613       32,865  
Share premium     96,568       86,271       113,355  
Treasury shares     (1,736 )     (1,736 )     (2,038 )
Transaction reserve with non-controlling interests     14,757       5,697       17,322  
Reserves     6,764       14,338       7,940  
Accumulated deficit     (1,123 )     (11,561 )     (1,318 )
Total equity attributed to shareholders of the Company     143,228       118,622       168,126  
Non-controlling interest     25,864       10,663       30,360  
Total equity     169,092       129,285       198,486  
Total liabilities and equity     759,444       677,257       891,461  


* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   


Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Comprehensive Income  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    Unaudited     Audited     Unaudited  
    € in thousands (except per share data)     Convenience Translation into US$*  
Revenues     12,729       12,333       32,865       31,789       40,467       38,578  
Operating expenses     (5,155 )     (4,982 )     (14,361 )     (14,505 )     (19,803 )     (16,857 )
Depreciation and amortization expenses     (4,362 )     (4,111 )     (12,850 )     (12,342 )     (15,887 )     (15,084 )
Gross profit     3,212       3,240       5,654       4,942       4,777       6,637  
                                                 
Project development costs     (511 )     (1,030 )     (3,381 )     (3,311 )     (4,101 )     (3,969 )
General and administrative expenses     (1,781 )     (1,645 )     (5,165 )     (4,679 )     (6,063 )     (6,063 )
Share of profits of equity accounted investee     16,999       3,486       17,011       5,295       11,062       19,968  
Other income (expenses), net     (153 )     2,885       1,278       2,885       3,409       1,500  
Operating profit     17,766       6,936       15,397       5,132       9,084       18,073  
                                                 
Financing income     7,853       4,553       9,596       6,977       2,495       11,264  
Financing income (expenses) in connection with derivatives and warrants, net     (1,037 )     (90 )     (599 )     2,762       1,140       (703 )
Financing expenses in connection with projects finance     (1,928 )     (1,693 )     (5,016 )     (4,646 )     (6,190 )     (5,888 )
Financing expenses in connection with debentures     (971 )     (1,486 )     (4,971 )     (5,048 )     (6,641 )     (5,835 )
Interest expenses on minority shareholder loan     (424 )     (528 )     (1,355 )     (1,616 )     (2,144 )     (1,591 )
Other financing expenses     (11,209 )     (145 )     (6,349 )     (428 )     (8,311 )     (7,453 )
Financing income (expenses), net     (7,716 )     611       (8,694 )     (1,999 )     (19,651 )     (10,206 )
                                                 
Profit before taxes on income     10,050       7,547       6,703       3,133       (10,567 )     7,867  
Tax benefit (taxes on income)     19       (916 )     1,790       72       1,424       2,101  
Profit (loss) for the period from continuing operations     10,069       6,631       8,493       3,205       (9,143 )     9,968  
Profit from discontinued operation (net of tax)     -       -       -       79       137       -  
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Profit (loss) attributable to:                                                
Owners of the Company     10,128       6,104       10,438       4,670       (6,524 )     12,252  
Non-controlling interests     (59 )     527       (1,945 )     (1,386 )     (2,482 )     (2,284 )
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Other comprehensive income (loss) item that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss:                                                
Foreign currency translation differences for foreign operations     2,911       (4,719 )     (6,137 )     (5,152 )     8,007       (7,204 )
Foreign currency translation differences for foreign operations that were recognized in profit or loss     -       -       -       255       255       -  
Effective portion of change in fair value of cash flow hedges     (2,248 )     286       386       9,412       5,631       453  
Net change in fair value of cash flow hedges transferred to profit or loss     (539 )     1,363       (2,821 )     (1,921 )     (813 )     (3,312 )
Total other comprehensive income (loss)     124       (3,070 )     (8,572 )     2,594       13,080       (10,063 )
                                                 
Total other comprehensive income (loss) attributable to:                                                
Owners of the Company     1,281       (4,020 )     (7,574 )     (1,315 )     10,039       (8,891 )
Non-controlling interests     (1,157 )     950       (998 )     3,909       3,041       (1,172 )
Total other comprehensive income (loss) for the period     124       (3,070 )     (8,572 )     2,594       13,080       (10,063 )
Total comprehensive income (loss) for the period     10,193       3,561       (79 )     5,878       4,074       (95 )
                                                 
Total comprehensive income (loss) attributable to:                                                
Owners of the Company     11,409       2,084       2,864       3,355       3,515       3,361  
Non-controlling interests     (1,216 )     1,477       (2,943 )     2,523       559       (3,456 )
Total comprehensive income (loss) for the period     10,193       3,561       (79 )     5,878       4,074       (95 )


* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US $ 1.174)
   


Ellomay Capital Ltd. and its Subsidiaries  
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (cont’d)  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended
December 31,
    For the nine months ended
September 30,
 
    2025     2024     2025     2024     2024     2025  
    Unaudited     Audited     Unaudited  
    € in thousands (except per share data)     Convenience Translation into US$*  
Basic profit (loss) per share     0.79       0.47       0.81       0.36       (0.51 )     0.95  
Diluted profit (loss) per share     0.79       0.47       0.81       0.36       (0.51 )     0.95  
                                                 
Basic profit (loss) per share continuing operations     0.79       0.47       0.81       0.35       (0.52 )     0.95  
Diluted profit (loss) per share continuing operations     0.79       0.47       0.81       0.35       (0.52 )     0.95  
                                                 
Basic profit per share discontinued operation     -       -       -       0.01       0.01       -  
Diluted profit per share discontinued operation     -       -       -       0.01       0.01       -  


* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   


Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Retained earnings (accumulated Deficit)     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    € in thousands  
For the nine months ended September 30, 2025 (unaudited):                                                            
Balance as at January 1, 2025     25,613       86,271       (11,561 )     (1,736 )     8,446       5,892       5,697       118,622       10,663       129,285  
Profit for the period                     10,438                                       10,438       (1,945 )     8,493  
Other comprehensive loss for the period                             -       (6,220 )     (1,354 )             (7,574 )     (998 )     (8,572 )
Total comprehensive loss for the period     -       -       10,438       -       (6,220 )     (1,354 )     -       2,864       (2,943 )     (79 )
Transactions with owners of the Company, recognized directly in equity:                                                                                
Sale of shares in subsidiaries from non-controlling interests     -       -       -       -       -       -       9,060       9,060       16,997       26,057  
Options exercise     3       5       -       -       -       -       -       8       -       8  
Issuance of ordinary shares     2,382       10,281       -       -       --       -       -       12,663       -       12,663  
Issuance of capital note to non-controlling interest     -       -       -       -       -       -       -       -       1,147       1,147  
Share-based payments     -       11       -       -       -       -       -       11       -       11  
Balance as at September 30, 2025     27,998       96,568       (1,123 )     (1,736 )     2,226       4,538       14,757       143,228       25,864       169,092  
                                                                                 
For the nine months ended September 30, 2024 (unaudited):                                                                                
Balance as at January 1, 2024     25,613       86,159       (5,037 )     (1,736 )     385       3,914       5,697       114,995       10,104       125,099  
Profit (loss) for the period     -       -       4,670       -       -       -       -       4,670       (1,386 )     3,284  
Other comprehensive income (loss) for the period     -       -       -       -       (4,762 )     3,447       -       (1,315 )     3,909       2,594  
Total comprehensive income (loss) for the period     -       -       4,670       -       (4,762 )     3,447       -       3,355       2,523       5,878  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments     -       91       -       -       -       -       -       91       -       91  
Balance as at September 30, 2024     25,613       86,250       (367 )     (1,736 )     (4,377 )     7,361       5,697       118,441       12,627       131,068  


   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity (cont’d)  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Accumulated deficit     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    € in thousands  
For the year ended December 31, 2024 (audited):                                                            
Balance as at January 1, 2024     25,613       86,159       (5,037 )     (1,736 )     385       3,914       5,697       114,995       10,104       125,099  
Loss for the year     -       -       (6,524 )     -       -       -       -       (6,524 )     (2,482 )     (9,006 )
Other comprehensive income for the year     -       -       -       -       8,061       1,978       -       10,039       3,041       13,080  
Total comprehensive income (loss) for the year     -       -       (6,524 )     -       8,061       1,978       -       3,515       559       4,074  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments     -       112       -       -       -       -       -       112       -       112  
Balance as at December 31, 2024     25,613       86,271       (11,561 )     (1,736 )     8,446       5,892       5,697       118,622       10,663       129,285  


   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity (cont’d)  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Accumulated deficit     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$1.174)  
For the nine months ended September 30, 2025 (unaudited):                                                            
Balance as at January 1, 2025     30,065       101,268       (13,570 )     (2,038 )     9,915       6,916       6,687       139,243       12,518       151,761  
Profit for the period     -       -       12,252       -       -       -       -       12,252       (2,284 )     9,968  
Other comprehensive loss for the period     -       -       -       -       (7,301 )     (1,590 )     -       (8,891 )     (1,172 )     (10,063 )
Total comprehensive loss for the period     -       -       12,252       -       (7,301 )     (1,590 )     -       3,361       (3,456 )     (95 )
Transactions with owners of the Company, recognized directly in equity:                                                                                
Sale of shares in subsidiaries from non-controlling interests     -       -       -       -       -       -       10,635       10,635       19,952       30,587  
Options exercise     4       6       -       -       -       -       -       10       -       10  
Issuance of ordinary shares     2,796       12,068       -       -       -       -       -       14,864       -       14,864  
Issuance of capital note to non-controlling interest     -       -       -       -       -       -       -       -       1,346       1,346  
Share-based payments     -       13       -       -       -       -       -       13       -       13  
Balance as at September 30, 2025     32,865       113,355       (1,318 )     (2,038 )     2,614       5,326       17,322       168,126       30,360       198,486  


   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Cash Flow  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    € in thousands     Convenience Translation into US$*  
Cash flows from operating activities                                    
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Adjustments for:                                                
Financing income (expenses), net     7,716       (611 )     8,694       1,595       19,247       10,206  
Profit (loss) from settlement of derivatives contract     -       (149 )     -       50       316       -  
Impairment losses on assets of disposal groups classified as held-for-sale     -       -       -       405       405       -  
Depreciation and amortization     4,362       4,111       12,850       12,390       15,935       15,084  
Share-based payment transactions     7       30       11       91       112       13  
Share of profits of equity accounted investees     (16,999 )     (3,486 )     (17,011 )     (5,295 )     (11,062 )     (19,968 )
Change in trade receivables and other receivables     (1,083 )     (4 )     6,302       (3,218 )     (8,824 )     7,398  
Change in other assets     469       871       (533 )     876       3,770       (626 )
Change in receivables from concessions project     -       -       -       793       793       -  
Change in trade payables     (501 )     554       2,177       (79 )     (31 )     2,555  
Change in other payables     1,293       (2,052 )     (3,517 )     (293 )     4,455       (4,128 )
Income tax expense (tax benefit)     (19 )     916       (1,790 )     (77 )     (1,429 )     (2,101 )
Income taxes refund (paid)     7       (133 )     (20 )     346       623       (23 )
Interest received     878       226       2,222       1,932       2,537       2,608  
Interest paid     (2,721 )     (1,827 )     (9,347 )     (7,255 )     (9,873 )     (10,972 )
      (6,591 )     (1,554 )     38       2,261       16,974       46  
Net cash provided by operating activities     3,478       5,077       8,531       5,545       7,968       10,014  
                                                 
Cash flows from investing activities                                                
Acquisition of fixed assets     (22,106 )     (30,453 )     (59,036 )     (50,046 )     (72,922 )     (69,299 )
Interest paid capitalized to fixed assets     (2,071 )     (507 )     (3,898 )     (1,628 )     (2,515 )     (4,576 )
Proceeds from sale of investments     -       -       -       9,267       9,267       -  
Advances on account of investments     547       (109 )     547       (163 )     (163 )     642  
Proceeds from advances on account of investments     -       -       -       -       514       -  
Proceeds from (investment in) settlement of derivatives, net     -       65       -       224       (316 )     -  
Proceeds from restricted cash, net     10,530       38       1,364       157       689       1,601  
Proceeds from (investment in) short term deposit     -       79       -       (1,404 )     1,004       -  
Net cash used in investing activities     (13,100 )     (30,887 )     (61,023 )     (43,593 )     (64,442 )     (71,632 )
                                                 
Cash flows from financing activities                                                
Issuance of warrants     -       -       475       3,735       2,449       558  
Cost associated with long-term loans     (1,445 )     (545 )     (2,502 )     (2,011 )     (2,567 )     (2,937 )
Proceeds from option exercise     8       -       8       -       -       9  
Proceeds from private placement of shares     12,663       -       12,663       -       -       14,864  
Sale of shares in subsidiaries to non-controlling interests     12,214       -       33,066       -       -       38,814  
Payment of principal of lease liabilities     (279 )     (179 )     (731 )     (665 )     (2,941 )     (858 )
Proceeds from long and short-term loans     1,129       8,829       19,028       19,307       19,482       22,336  
Repayment of long-term loans     (23,387 )     (441 )     (30,140 )     (7,108 )     (11,776 )     (35,379 )
Repayment of debentures     -       -       (35,691 )     (35,845 )     (35,845 )     (41,895 )
Proceeds from the sale of tax credits     10,160       -       10,160       -       -       11,926  
Proceeds from issuance of debentures, net     -       11,966       56,729       57,756       74,159       66,591  
Net cash provided by financing activities     11,063       19,630       63,065       35,169       42,961       74,029  
                                                 
Effect of exchange rate fluctuations on cash and cash equivalents     1,347       (1,408 )     (2,419 )     (220 )     3,092       (2,840 )
Increase (decrease) in cash and cash equivalents     2,788       (7,588 )     8,154       (3,099 )     (10,421 )     9,571  
Cash and cash equivalents at the beginning of the period     46,500       56,044       41,134       51,127       51,127       48,285  
Cash from (used in) disposal groups classified as held-for-sale     -       -       -       428       428       -  
Cash and cash equivalents at the end of the period     49,288       48,456       49,288       48,456       41,134       57,856  


* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   

  

Ellomay Capital Ltd. and its Subsidiaries  
Operating Segments (Unaudited)  
   
    Italy     Spain     USA     Netherlands     Israel     Total              
          Subsidized     28 MV                                   reportable           Total  
    Solar     Plants     Solar     Talasol     Solar     Biogas     Dorad     Manara     segments     Reconciliations     consolidated  
    For the nine months ended September 30, 2025  
    € in thousands  
                                                                   
Revenues     3,801       2,233       1,171       14,800       542       10,318       50,016       -       82,881       (50,016 )     32,865  
Operating expenses     (404 )     (394 )     (533 )     (3,604 )     (342 )     (9,085 )     (37,276 )     -       (51,638 )     37,277       (14,361 )
Depreciation expenses     (674 )     (690 )     (757 )     (8,520 )     (309 )     (1,840 )     (4,026 )     -       (16,816 )     3,966       (12,850 )
Gross profit (loss)     2,723       1,149       (119 )     2,676       (109 )     (607 )     8,714       -       14,427       (8,773 )     5,654  
                                                                                         
Project development costs                                                                                     (3,381 )
General and administrative expenses                                                                                     (5,165 )
Share of profit of equity accounted investee                                                                                     17,011  
Other income, net                                                                                     1,278  
Operating profit                                                                                     15,397  
Financing income                                                                                     9,596  
Financing income in connection with derivatives and warrants, net                                                                                     (599 )
Financing expenses in connection with projects finance                                                                                     (5,016 )
Financing expenses in connection with debentures                                                                                     (4,971 )
Interest expenses on minority shareholder loan                                                                                     (1,355 )
Other financing expenses                                                                                     (6,349 )
Financing expenses, net                                                                                     (8,694 )
Profit before taxes on income                                                                                     6,703  
                                                                                         
Segment assets as at September 30, 2025     118,581       12,962       18,919       215,474       72,331       30,083       114,738       191,501       774,589       (15,145 )     759,444  


   
Ellomay Capital Ltd. and its Subsidiaries  
Reconciliation of Profit (Loss) to EBITDA (Unaudited)  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    € in thousands     Convenience Translation into US$ in thousands*  
Net profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Financing (income) expenses, net     7,716       (611 )     8,694       1,999       19,651       10,206  
Taxes on income (Tax benefit)     (19 )     916       (1,790 )     (72 )     (1,424 )     (2,101 )
Depreciation and amortization     4,362       4,111       12,850       12,342       15,887       15,084  
EBITDA     22,128       11,047       28,247       17,553       25,108       33,157  


* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders
 

Financial Covenants

Pursuant to the Deeds of Trust governing the Company’s Series D, Series E, Series F and Series G Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 30, 2025, and below.

Net Financial Debt

As of September 30, 2025, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €164.1 million (consisting of approximately €310.72 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €213.43 million in connection with (i) the Series D Convertible Debentures issuance (in February 2021), (ii) the Series E Secured Debentures issuance (in February 2023), (iii) the Series F Debentures issuance (in January, April, August and November 2024) and (iv) the Series G Debentures issuance (in February 2025)), net of approximately €49.3 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €310.74 million of project finance and related hedging transactions of the Company’s subsidiaries). The Net Financial Debt and other information included in this disclosure do not include the private placement of Series G Debentures consummated in December 2025.

2 The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.3 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.
   
3 The amount of the debentures provided above includes an amount of approximately €5.9 million associated costs, which was capitalized and discount or premium and therefore offset from the debentures amount that is recorded in the Company’s balance sheet. This amount also includes the accrued interest as at September 30, 2025 in the amount of approximately €0.9 million.
   
4 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €160.2 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA5 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30,
2025
 
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters6     1,419  
Adjusted EBITDA as defined the Series D Deed of Trust     41,450  


5 The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”
   
6 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series E Debenture Holders

The Deed of Trust governing the Company’s Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series E Deed of Trust) was approximately €160.2 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA7 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters8     1,419  
Adjusted EBITDA as defined the Series E Deed of Trust     41,450  
         

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. (“Ellomay Luzon Energy”)), if any, which were pledged to the holders of the Company’s Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of September 30, 2025, the value of the assets pledged to the holders of the Series E Debentures in the Company’s books (unaudited) is approximately €57.5 million (approximately NIS 223.3 million based on the exchange rate as of such date).

7 The term “Adjusted EBITDA” is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”
   
8 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series F Debenture Holders

The Deed of Trust governing the Company’s Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series F Deed of Trust) was approximately €159.6 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA9 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters10     1,419  
Adjusted EBITDA as defined the Series F Deed of Trust     41,450  


9 The term “Adjusted EBITDA” is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”
   
10 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series G Debenture Holders

The Deed of Trust governing the Company’s Series G Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series G Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series G Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series G Deed of Trust) was approximately €159.6 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA11 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series G Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters12     1,419  
Adjusted EBITDA as defined the Series G Deed of Trust     41,450  


11 The term “Adjusted EBITDA” is defined in the Series G Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series G Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series G Deed of Trust). The Series G Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series G Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”
   
12 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions